Granules India (GRANULES) Share Price Falls 2.25% Today to Rs 851.75

Published:   28 September 2026 at 1:22:54 PM IST

Granules India Share Price declined to Rs 851.75 today, down 2.25% from the previous close of Rs 871.35, with the company valued at a market capitalisation of Rs 23,768.67 Cr. The move makes Granules India stock news relevant for investors tracking Granules India Share Price Today, especially because the supplied data confirms the fall but does not establish a company-specific catalyst. In this Granules India Share Price update, the key facts are straightforward: the stock opened at Rs 869.85, traded between Rs 873.20 and Rs 851.60, and closed near the session low. Univest is watching the same verified numbers to separate what happened from what can be inferred, and to keep the analysis anchored to facts rather than assumptions.

Granules India Share Price is therefore best read as a same-day decline with no disclosed trigger in the data. The market-cap category is Large Cap, which provides company-size context only. For readers scanning Granules India stock news or asking why Granules India is falling today, the answer lies in the confirmed price action, valuation, and sector context rather than any unverified reason.

Granules India (GRANULES) Share Price Today: Price Action Analysis

Metric	Value
Current Price	Rs 851.75
Previous Close	Rs 871.35
Today's Move	-Rs 19.60 (-2.25%)
Open	Rs 869.85
High	Rs 873.2
Low	Rs 851.6
Turnover	Rs 1.41 crore
Market Capitalisation	Rs 23,768.67 crore
Market Cap Category	Large Cap

Granules India Share Price today moved from a previous close of Rs 871.35 to Rs 851.75, a fall of Rs 19.60 or 2.25%. The session opened at Rs 869.85, touched an intraday high of Rs 873.20 and a low of Rs 851.60. That places the closing price very close to the day’s low and below the opening level, which is the most visible part of the day’s price action.

The stock also recorded turnover of Rs 1.41 Cr. On its own, that is only a factual traded-value figure and should not be used to explain the move. The company’s Large Cap classification is relevant as context, but it does not by itself explain the decline. From a stock news perspective, the confirmed event is a modest single-day share price fall, not a broader statement on business quality or long-term direction. For anyone tracking Granules India Share Price Live, the immediate takeaway is that today’s move was negative, measured, and data-confirmed.

In Granules India Stock News terms, the day was defined by a lower close, a narrow intraday range, and a percentage decline that is clear enough to register on market screens. The next step is to read that move alongside the company’s fundamentals and sector benchmarks in the broader Granules India Share Price analysis.

Granules India (GRANULES) Fundamental Analysis

Metric	Value
Market Capitalisation	Rs 23,768.67 crore
P/E Ratio	35.89x
P/B Ratio	4.85x
ROE	14.13%
ROCE	15.74%
EPS	Rs 24.28
Book Value Per Share	Rs 179.7
Dividend Yield	0.2%

On profitability, ROE is 14.13% and ROCE is 15.74%. Those are useful context points for Granules India Stock Analysis because they show returns on shareholder equity and employed capital. In fundamental analysis terms, the company is not trading at a discount to the sector benchmark on valuation multiples, but the exact comparison belongs in the sector section. Granules India Financial Results are not part of this dataset, so this article stays with the supplied ratios rather than speculating on recent operating performance.

For readers comparing Granules India Share Price Today with financial quality measures, the key point is that the stock combines a large-cap market value, a mid-to-high P/E multiple, a P/B of 4.85 and a small dividend yield. Univest uses these facts to build a neutral Granules India Fundamental Analysis view that stays clear of forecasts and recommendations.

Sector and Industry Context

Metric	Value
Sector	Healthcare
Industry	Pharmaceuticals & Drugs
Benchmark Scope	same industry
Company P/E Ratio	35.89x
Benchmark Median P/E	32.87x
Benchmark Average P/E	49.63x
Benchmark P/E Range	3.46x to 735.85x
Company P/B Ratio	4.85x
Benchmark Median P/B	2.85x
Benchmark Average P/B	4.33x
Company ROE	14.13%
Benchmark Median ROE	11.48%
Benchmark Average ROE	10.04%
Company ROCE	15.74%
Benchmark Median ROCE	13.17%
Benchmark Average ROCE	12.82%
Company Market Capitalisation	Rs 23,768.67 crore
Benchmark Median Market Cap	Rs 732.57 crore
Benchmark Average Market Cap	Rs 14,043.26 crore

Granules India operates in Healthcare and the Pharmaceuticals & Drugs industry. The benchmark scope supplied here covers the same industry and includes 204 companies, which is important because Granules India Share Price should be read against that peer set rather than against a broad market average. In the benchmark data, the company’s P/E of 35.89 sits above the industry median of 32.87 and below the industry average of 49.63. Its P/B of 4.85 is above the median of 2.85 and above the average of 4.33.

On operating returns, Granules India’s ROE of 14.13% is above the industry median of 11.48% and above the average of 10.04%. Its ROCE of 15.74% is also above the industry median of 13.17% and above the average of 12.82%. The benchmark market-cap median is Rs 732.57 Cr and the average is Rs 14,043.26 Cr, while Granules India’s market capitalisation of Rs 23,768.67 Cr places it above both. That sector comparison is central to Granules India Share Price News because it shows where the company sits within the pharmaceuticals universe.

In industry terms, Granules India Share Price is being assessed in a field where valuation dispersion is wide: P/E ranges from 3.46 to 735.85, P/B from -22.29 to 35.45, and market capitalisation from Rs 3.98 Cr to Rs 4,44,716.74 Cr. Univest presents this context so readers can compare Granules India Share Price with the broader healthcare benchmark rather than judging today’s fall in isolation.

Peer Comparison

Company	Symbol	Market Cap (Cr)	P/E	P/B	ROE (%)	ROCE (%)
Sun Pharmaceutical Industries	SUNPHARMA	4,44,716.74	36.77	5.14	14.85	19.11
Divi's Laboratories	DIVISLAB	2,55,115.31	87.22	14.44	16.19	21.51
Torrent Pharmaceuticals	TORNTPHARM	1,89,613.38	86.94	21.13	26.76	19.27
Zydus Lifesciences	ZYDUSLIFE	1,19,899.96	26.57	4.45	19.69	21.39
Cipla	CIPLA	1,12,875.68	33.49	3.21	11.83	16

Among the supplied peers, Granules India’s market capitalisation of Rs 23,768.67 Cr is well below Sun Pharmaceutical Industries at Rs 4,44,716.74 Cr and Divi’s Laboratories at Rs 2,55,115.31 Cr, but above Zydus Lifesciences at Rs 1,19,899.96 Cr, Cipla at Rs 1,12,875.68 Cr and several others in the list. This makes Granules India a smaller company than the largest names in the peer set, while still remaining in the large-cap category supplied in the dataset.

On valuation, Granules India’s P/E of 35.89 is close to Sun Pharmaceutical Industries at 36.77 and lower than Divi’s Laboratories at 87.22, Torrent Pharmaceuticals at 86.94, Laurus Labs at 98.88 and Mankind Pharma at 50.06. Its P/B of 4.85 is above Cipla at 3.21 and Zydus Lifesciences at 4.45, but below Sun Pharmaceutical Industries at 5.14 and far below more expensive peer readings such as 14.44 and 21.13. Granules India Share Price therefore sits in the middle of a mixed peer valuation picture, with profitability metrics that are better than some peers and below others.

For Granules India Stock News readers, the peer list shows that today’s decline needs to be interpreted against a competitive pharmaceutical benchmark, not against a single comparable. Univest highlights these differences to make Granules India Share Price analysis more useful and more searchable.

Why Investors Are Watching Granules India

• Granules India Share Price fell 2.25% today to Rs 851.75 from Rs 871.35.
• The day’s range was Rs 851.60 to Rs 873.20, with opening price at Rs 869.85.
• Market capitalisation stands at Rs 23,768.67 Cr, and the company is classified as Large Cap.
• P/E is 35.89, P/B is 4.85, ROE is 14.13% and ROCE is 15.74%.
• In the same-industry benchmark, the company’s P/E, ROE and ROCE can be compared with 204 pharmaceuticals peers.

About Granules India

Granules India is classified under Healthcare and the Pharmaceuticals & Drugs industry. The dataset supplied for this article does not include a detailed business description, product list or revenue mix, so the company profile here is to the verified sector and industry classification. For Granules India Share Price readers, that still matters because sector identity is often the starting point for benchmark comparison, peer review and search intent around Granules India Company News.

Univest keeps the profile factual and compact, focusing only on verified labels such as industry and sector. That ensures Granules India Share Price analysis remains grounded in public data instead of generic business assumptions.

Track Granules India Share Price on Univest

Use Granules India (GRANULES) live share-price page,Univest top decliners screener,Univest market blogs to review live stock data, top decliners and related market analysis.

You can track Granules India Share Price on Univest for live price updates, market-cap context, valuation ratios, shareholding pattern, 52-week levels and market insights. The platform brings Granules India Stock Analysis, Granules India Fundamental Analysis and Granules India Stock News together in one place for quick review.

Univest also helps readers compare Granules India Share Price Today with sector benchmarks and peer data, making it easier to follow the stock’s price action as part of broader Granules India Share News coverage.

Frequently Asked Questions

Why is Granules India Share Price falling today?

Ans.  Granules India Share Price fell 2.25% to Rs 851.75 from Rs 871.35. The dataset confirms the price move, but it does not establish a company-specific catalyst for the decline. The previous close was Rs 871.35.

What is Granules India Share Price today?

Ans.  Granules India Share Price today is Rs 851.75. The stock closed Rs 19.60 lower than the previous close of Rs 871.35 after opening at Rs 869.85 and trading between Rs 873.20 and Rs 851.60.

What does Granules India’s market capitalisation show?

Ans.  Granules India’s market capitalisation is Rs 23,768.67 Cr. That places it well above the same-industry median of Rs 732.57 Cr and above the industry average of Rs 14,043.26 Cr in the supplied benchmark.

How does Granules India compare on valuation?

Ans.  Granules India trades at a P/E of 35.89 and a P/B of 4.85. In the same-industry benchmark, the company’s P/E is above the median of 32.87, while its P/B is above the median of 2.85.

What do ROE and ROCE say about Granules India?

Ans.  Granules India reports ROE of 14.13% and ROCE of 15.74%. Both are above the industry medians supplied for the same-industry benchmark, which helps place the stock in context alongside its peers.

How does Granules India compare with peers?

Ans.  Granules India’s market capitalisation is below Sun Pharma and Divi’s Laboratories, but above several other listed peers in the set. Its P/E of 35.89 is close to Sun Pharma and below higher-valued peers such as Divi’s and Torrent.